Ovation.io and PrecisionLife team to develop drug-response biomarkers for GLP-1 therapies
GLP-1 therapies are among the fastest-growing drug classes worldwide, projected to drive a $95 billion obesity market by 2030
GLP-1 therapies are among the fastest-growing drug classes worldwide, projected to drive a $95 billion obesity market by 2030
Renalyx will continue operating as an independent unit within the group
The viewer aims to help radiologists work smarter, faster, and more collaboratively, while reducing IT complexity and freeing up valuable clinical time
The deliveries bring the innovative medicine to communities heavily impacted by HIV just five months after U.S. FDA approval
The inclusion of broad-spectrum sunscreen in the WHO EML and EMLc follows an application submitted in November 2024 by the Global Albinism Alliance
Medroxyprogesterone acetate-SC is a three-month contraceptive that can be administered by healthcare workers or self-injected after appropriate training
WHO’s global SPECS 2030 target to increase effective refractive error coverage by 40% by 2030
We are taking Ayurveda to the world as a sustainable healthcare solution: Union Minister Prataprao Jadhav
The agreement includes plans for distribution, technology transfer, local manufacturing, new pharmaceutical product development
Subscribe To Our Newsletter & Stay Updated